Lista de obras - Andreas Behren - Dominio Público Uruguay

A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response

scientific article published on 30 September 2019

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

scientific article published on 18 March 2020

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients

artículo científico publicado en 2019

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

artículo científico publicado en 2013

AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells

artículo científico publicado en 2008

Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes

scientific article published on 13 August 2020

Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis

artículo científico publicado en 2019

Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.

artículo científico publicado en 2016

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer.

artículo científico publicado en 2015

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

artículo científico publicado en 2019

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

artículo científico publicado en 2013

BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage

artículo científico publicado en 2013

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

artículo científico publicado en 2020

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

artículo científico publicado en 2017

Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces

artículo científico publicado en 2016

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma

artículo científico publicado en 2015

Characterising the phenotypic evolution of circulating tumour cells during treatment.

artículo científico publicado en 2018

Editorial: Cellular and Phenotypic Plasticity in Cancer

artículo científico publicado en 2015

Evolving role of tumor antigens for future melanoma therapies.

artículo científico publicado en 2014

FOXP3 is not mutated in human melanoma

artículo científico publicado en 2012

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis

artículo científico publicado en 2014

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

artículo científico publicado en 2012

Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM.

artículo científico publicado en 2016

Identifying and targeting determinants of melanoma cellular invasion.

artículo científico publicado en 2016

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

artículo científico publicado en 2014

Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes.

artículo científico publicado en 2019

Immunotherapy of Ipilimumab and Nivolumab in patients with advanced neuroendocrine tumours: a subgroup analysis of the CA209-538 clinical trial for rare cancers

artículo científico publicado en 2020

Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.

artículo científico publicado en 2010

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

artículo científico publicado en 2013

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.

artículo científico publicado en 2016

Methylation dependent gold adsorption behaviour identifies cancer derived extracellular vesicular DNA

artículo científico publicado en 2020

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma.

artículo científico publicado en 2016

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

artículo científico publicado en 2015

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

artículo científico publicado en 2018

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

artículo científico publicado en 2015

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

artículo científico publicado en 2017

Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway

artículo científico publicado en 2005

Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion

artículo científico publicado en 2009

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

artículo científico publicado en 2015

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

artículo científico publicado en 2020

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma

scientific article published on 16 September 2020

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile

artículo científico publicado en 2012

Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

artículo científico publicado en 2016

The Ludwig institute for cancer research Melbourne melanoma cell line panel

artículo científico publicado en 2013

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

artículo científico publicado en 2018

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

artículo científico publicado en 2014

The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells

artículo científico publicado en 2005

The role of circulating microRNA in hepatocellular carcinoma.

artículo científico publicado en 2015

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma

artículo científico publicado en 2014

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma

artículo científico publicado en 2020

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.

artículo científico publicado en 2016

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma

artículo científico publicado en 2015

Whole-genome landscapes of major melanoma subtypes.

artículo científico publicado en 2017

Lista de obras de Andreas Behren

A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells

Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes

Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis

Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer.

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma

Characterising the phenotypic evolution of circulating tumour cells during treatment.

Editorial: Cellular and Phenotypic Plasticity in Cancer

Evolving role of tumor antigens for future melanoma therapies.

FOXP3 is not mutated in human melanoma

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM.

Identifying and targeting determinants of melanoma cellular invasion.

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes.

Immunotherapy of Ipilimumab and Nivolumab in patients with advanced neuroendocrine tumours: a subgroup analysis of the CA209-538 clinical trial for rare cancers

Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.

Methylation dependent gold adsorption behaviour identifies cancer derived extracellular vesicular DNA

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma.

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway

Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile

Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

The Ludwig institute for cancer research Melbourne melanoma cell line panel

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells

The role of circulating microRNA in hepatocellular carcinoma.

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma

Whole-genome landscapes of major melanoma subtypes.